Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07132814 · ClinicalTrials.gov registry record · NA

Abuse Liability for Five Modern Oral Nicotine Products

A NA study of Smoking and Tobacco Use, sponsored by RAI Services Company.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07132814 is a NA study of Smoking and Tobacco Use that is actively recruiting participants, run by RAI Services Company. The registered enrollment target is 40 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07132814, a NA study of Smoking and Tobacco Use, is actively recruiting participants, sponsored by RAI Services Company.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This is a two-site, open-label, randomized, 4-way (2 arm) cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]) and plasma nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use of the study investigational products (IPs) by generally healthy smokers

Interventions

  • OTHER Product A
  • OTHER Product B
  • OTHER Product C
  • OTHER Product D
  • OTHER Product E

Study Locations (1)

Kansas

  • Dr. Vince Clinical Research - Overland Park

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-12-15
Est. Completion 2026-08-31
Phase NA

Sponsor

RAI Services Company

42 total trials

What the Registry Record Tells You About NCT07132814

The ClinicalTrials.gov registry entry for NCT07132814 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (91% lower). The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Smoking appearing as the primary indexed condition, and to 5 interventions - of which Product A is the first listed.

NCT07132814 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT07132814 about?

NCT07132814 is a clinical study titled "Abuse Liability for Five Modern Oral Nicotine Products". This is a two-site, open-label, randomized, 4-way (2 arm) cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]) and plasma nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use ...

What is the current status of trial NCT07132814?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-12-15. Estimated completion is 2026-08-31.

What conditions does trial NCT07132814 study?

This clinical trial studies the following conditions: Smoking, Tobacco Use, Tobacco Smoking, Smoking Behaviors.

What interventions are being tested in trial NCT07132814?

The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product E (OTHER).

Who is sponsoring clinical trial NCT07132814?

This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07132814 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.